Ginkgo Bioworks Holdings, Inc. Class A Common Stock
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
Share · US37611X1000 · DNA (XNYS)
Overview Financial Indicators
7,57 USD
3,87 % 0,28 USD
NYSE (XNYS) · Current prices and charts at MoneyPeak
06.06.2025 23:34

Current Prices from Ginkgo Bioworks Holdings, Inc. Class A Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
DNA
USD
06.06.2025 23:34
7,57 USD
7,22 USD
+4,85 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 7,68 % 2,30 % 0,40 % -35,08 % -63,19 % -98,13 %

Company Profile for Ginkgo Bioworks Holdings, Inc. Class A Common Stock Share

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Company Data

Name Ginkgo Bioworks Holdings, Inc. Class A Common Stock
Company Ginkgo Bioworks Holdings, Inc.
Symbol DNA
Website https://www.ginkgobioworks.com
Primary Exchange XNYS NYSE
ISIN US37611X1000
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Jason Kelly Ph.D.
Market Capitalization 440 Mio
Country United States of America
Currency USD
Employees 0,8 T
Address 27 Drydock Avenue, 02210 Boston
IPO Date 2021-04-19
Dividends from 'Ginkgo Bioworks Holdings, Inc. Class A Common Stock'
Ex-Date Dividend per Share
19.05.2025 0,08 USD
18.02.2025 0,08 USD
12.11.2024 0,08 USD
14.08.2024 0,08 USD
17.05.2024 0,08 USD
16.02.2024 0,08 USD
10.11.2023 0,08 USD
11.08.2023 0,08 USD
18.05.2023 0,08 USD
17.02.2023 0,08 USD

Stock Splits

Date Split
20.08.2024 1:40

ID Changes

Date From To
20.07.1999 GNE DNA

Ticker Symbols

Name Symbol
NYSE DNA

More Shares

Investors who Ginkgo Bioworks Holdings, Inc. Class A Common Stock hold also have the following shares in their portfolio:
BAIDU 12/22
BAIDU 12/22 Bond
DANAHER CORP20/50
DANAHER CORP20/50 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025